Trademark: 87324025
Word
SARAPACK
Status
Dead
Status Code
606
Status Date
Monday, August 17, 2020
Serial Number
87324025
Mark Type
4000
Filing Date
Friday, February 3, 2017
Published for Opposition
Tuesday, May 16, 2017
Abandoned Date
Monday, August 17, 2020

Trademark Owner History

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and formulations pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body

Trademark Events
Aug 17, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 17, 2020
Abandonment - No Use Statement Filed
Jan 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2020
Extension 5 Granted
Jan 6, 2020
Extension 5 Filed
Jan 10, 2020
Case Assigned To Intent To Use Paralegal
Jan 6, 2020
Teas Extension Received
Jun 18, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2019
Extension 4 Granted
Jun 14, 2019
Extension 4 Filed
Jun 14, 2019
Teas Extension Received
Dec 11, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 7, 2018
Extension 3 Granted
Dec 7, 2018
Extension 3 Filed
Dec 7, 2018
Teas Extension Received
Jul 3, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 29, 2018
Extension 2 Granted
Jun 29, 2018
Extension 2 Filed
Jun 29, 2018
Teas Extension Received
Dec 12, 2017
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2017
Extension 1 Granted
Dec 8, 2017
Extension 1 Filed
Dec 8, 2017
Teas Extension Received
Jul 11, 2017
Noa E-Mailed - Sou Required From Applicant
May 16, 2017
Official Gazette Publication Confirmation E-Mailed
May 16, 2017
Published For Opposition
Apr 26, 2017
Notification Of Notice Of Publication E-Mailed
Apr 11, 2017
Law Office Publication Review Completed
Apr 10, 2017
Assigned To Lie
Mar 15, 2017
Approved For Pub - Principal Register
Mar 13, 2017
Notification Of Letter Of Suspension E-Mailed
Mar 13, 2017
Letter Of Suspension E-Mailed
Mar 13, 2017
Suspension Letter Written
Mar 13, 2017
Assigned To Examiner
Feb 8, 2017
New Application Office Supplied Data Entered In Tram
Feb 7, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24